Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

PHASE2RecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

December 15, 2024

Study Completion Date

January 15, 2025

Conditions
CarcinomaNeoplasia; Intraepithelial, CervixGlandular NeoplasmsEpithelial NeoplasmNeoplasms
Interventions
DIETARY_SUPPLEMENT

Glizigen® + Ocoxin-Viusid®

"* Glizigen® spray, topical use, 2 times a day for 6 months with an interruption for 2 months at the end of the third month.~* Ocoxin®-Viusid® 60 ml daily (1 vial every 12 hours) by oral route for 8 months, preferably administered after breakfast and lunch, without interruption."

Trial Locations (1)

10500

RECRUITING

Our Lady of Rule No. 52 &/Remedios and Quiroga, Luyano, Havana

All Listed Sponsors
lead

Catalysis SL

INDUSTRY